Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 69

    1.

    Adenylyl cyclases as innovative therapeutic goals.

    Pavan B, Biondi C, Dalpiaz A.

    Drug Discov Today. 2009 Oct;14(19-20):982-91. Epub 2009 Jul 26.PMID: 19638320 [PubMed - in process]Related articles

    3.

    Zolpidem-induced sleep-driving.

    Doane JA, Dalpiaz AS.

    Am J Med. 2008 Nov;121(11):e5. No abstract available. PMID: 18954831 [PubMed - indexed for MEDLINE]Related articles

    4.

    An RPE cell line as a useful in vitro model for studying retinoic acid receptor beta: expression and affinity.

    Pavan B, Dalpiaz A, Biondi C, Nieddu M, De Luca A, Prasad PD, Paganetto G, Favaloro B.

    Biosci Rep. 2008 Dec;28(6):327-34.PMID: 18673301 [PubMed - indexed for MEDLINE]Related articles

    5.

    Progress in drug delivery to the central nervous system by the prodrug approach.

    Pavan B, Dalpiaz A, Ciliberti N, Biondi C, Manfredini S, Vertuani S.

    Molecules. 2008 May 1;13(5):1035-65. Review.PMID: 18560328 [PubMed - indexed for MEDLINE]Related articles

    6.

    Treatment of non-alcoholic fatty liver disease.

    Tolman KG, Dalpiaz AS.

    Ther Clin Risk Manag. 2007 Dec;3(6):1153-63.PMID: 18516264 [PubMed - in process]Related articlesFree article

    7.

    Brain uptake of an anti-ischemic agent by nasal administration of microparticles.

    Dalpiaz A, Gavini E, Colombo G, Russo P, Bortolotti F, Ferraro L, Tanganelli S, Scatturin A, Menegatti E, Giunchedi P.

    J Pharm Sci. 2008 Nov;97(11):4889-903.PMID: 18300305 [PubMed - indexed for MEDLINE]Related articles

    8.

    Solid lipid microparticles for the stability enhancement of the polar drug N6-cyclopentyladenosine.

    Dalpiaz A, Mezzena M, Scatturin A, Scalia S.

    Int J Pharm. 2008 May 1;355(1-2):81-6. Epub 2007 Nov 29.PMID: 18178347 [PubMed - indexed for MEDLINE]Related articles

    9.

    Metabolic flux analysis using stoichiometric models for Aspergillus niger: comparison under glucoamylase-producing and non-producing conditions.

    Melzer G, Dalpiaz A, Grote A, Kucklick M, Göcke Y, Jonas R, Dersch P, Franco-Lara E, Nörtemann B, Hempel DC.

    J Biotechnol. 2007 Dec 1;132(4):405-17. Epub 2007 Aug 26.PMID: 17931730 [PubMed - indexed for MEDLINE]Related articles

    10.

    Selection of reference genes for normalisation of specific gene quantification data of Aspergillus niger.

    Bohle K, Jungebloud A, Göcke Y, Dalpiaz A, Cordes C, Horn H, Hempel DC.

    J Biotechnol. 2007 Dec 1;132(4):353-8. Epub 2007 Aug 7.PMID: 17868942 [PubMed - indexed for MEDLINE]Related articles

    11.

    Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheres.

    Contado C, Dalpiaz A, Leo E, Zborowski M, Williams PS.

    J Chromatogr A. 2007 Jul 20;1157(1-2):321-35. Epub 2007 Apr 21.PMID: 17482199 [PubMed - indexed for MEDLINE]Related articles

    12.

    Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease.

    Tolman KG, Fonseca V, Dalpiaz A, Tan MH.

    Diabetes Care. 2007 Mar;30(3):734-43. Review. No abstract available. PMID: 17327353 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate.

    Dalpiaz A, Filosa R, de Caprariis P, Conte G, Bortolotti F, Biondi C, Scatturin A, Prasad PD, Pavan B.

    Int J Pharm. 2007 May 4;336(1):133-9. Epub 2006 Nov 28.PMID: 17184941 [PubMed - indexed for MEDLINE]Related articles

    14.

    Nuclear retinoic acid receptor beta as a tool in chemoprevention trials.

    Pavan B, Biondi C, Dalpiaz A.

    Curr Med Chem. 2006;13(29):3553-63. Review.PMID: 17168722 [PubMed - indexed for MEDLINE]Related articles

    15.

    Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: effect of steroids, flavonoids and NSAIDs.

    Biondi C, Pavan B, Dalpiaz A, Medici S, Lunghi L, Vesce F.

    Mol Hum Reprod. 2007 Jan;13(1):77-83. Epub 2006 Nov 8.PMID: 17092984 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Polymeric nanoparticles as drug controlled release systems: a new formulation strategy for drugs with small or large molecular weight.

    Leo E, Scatturin A, Vighi E, Dalpiaz A.

    J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3070-9.PMID: 17048520 [PubMed - indexed for MEDLINE]Related articles

    17.

    Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity.

    Cortesi R, Argnani R, Esposito E, Dalpiaz A, Scatturin A, Bortolotti F, Lufino M, Guerrini R, Cavicchioni G, Incorvaia C, Menegatti E, Manservigi R.

    Int J Pharm. 2006 Jul 6;317(1):90-100. Epub 2006 Apr 5.PMID: 16600535 [PubMed - indexed for MEDLINE]Related articles

    18.

    Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A1 receptors of LUF5831, a novel nonadenosine-like agonist.

    Heitman LH, Mulder-Krieger T, Spanjersberg RF, von Frijtag Drabbe Künzel JK, Dalpiaz A, IJzerman AP.

    Br J Pharmacol. 2006 Mar;147(5):533-41.PMID: 16444290 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Nanoparticle formulation may affect the stabilization of an antiischemic prodrug.

    Leo E, Contado C, Bortolotti F, Pavan B, Scatturin A, Tosi G, Manfredini S, Angusti A, Dalpiaz A.

    Int J Pharm. 2006 Jan 3;307(1):103-13. Epub 2005 Nov 14.PMID: 16289882 [PubMed - indexed for MEDLINE]Related articles

    20.

    Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour.

    Biondi C, Pavan B, Dalpiaz A, Valerio A, Spisani S, Vesce F.

    J Reprod Immunol. 2005 Dec;68(1-2):71-83. Epub 2005 Oct 19.PMID: 16236365 [PubMed - indexed for MEDLINE]Related articles

    21.

    Caffeine intake induces an alteration in human neutrophil A2A adenosine receptors.

    Varani K, Portaluppi F, Gessi S, Merighi S, Vincenzi F, Cattabriga E, Dalpiaz A, Bortolotti F, Belardinelli L, Borea PA.

    Cell Mol Life Sci. 2005 Oct;62(19-20):2350-8.PMID: 16143823 [PubMed - indexed for MEDLINE]Related articles

    22.

    Synthesis and biological evaluation of pro-drugs of GW196771, a potent glycine antagonist acting at the NMDA receptor.

    Angusti A, Durini E, Vertuani S, Dalpiaz A, Ruffo A, Di Fabio R, Donati D, Pentassuglia G, Vitulli G, Barnaby RJ, Manfredini S.

    Farmaco. 2005 May;60(5):393-7.PMID: 15885689 [PubMed - indexed for MEDLINE]Related articles

    23.

    Parecoxib: a shift in pain management?

    Dalpiaz AS, Peterson D.

    Expert Rev Neurother. 2004 Mar;4(2):165-77. Review.PMID: 15853557 [PubMed - indexed for MEDLINE]Related articles

    24.

    Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.

    Gilli P, Gilli G, Borea PA, Varani K, Scatturin A, Dalpiaz A.

    J Med Chem. 2005 Mar 24;48(6):2026-35.PMID: 15771445 [PubMed - indexed for MEDLINE]Related articles

    25.

    Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs.

    Dalpiaz A, Pavan B, Vertuani S, Vitali F, Scaglianti M, Bortolotti F, Biondi C, Scatturin A, Tanganelli S, Ferraro L, Marzola G, Prasad P, Manfredini S.

    Eur J Pharm Sci. 2005 Mar;24(4):259-69. Epub 2004 Dec 19.PMID: 15734292 [PubMed - indexed for MEDLINE]Related articles

    26.

    Vitamin C and 6-amino-vitamin C conjugates of diclofenac: synthesis and evaluation.

    Dalpiaz A, Pavan B, Scaglianti M, Vitali F, Bortolotti F, Biondi C, Scatturin A, Manfredini S.

    Int J Pharm. 2005 Mar 3;291(1-2):171-81. Epub 2004 Dec 30.PMID: 15707744 [PubMed - indexed for MEDLINE]Related articles

    27.

    Narrative review: hepatobiliary disease in type 2 diabetes mellitus.

    Tolman KG, Fonseca V, Tan MH, Dalpiaz A.

    Ann Intern Med. 2004 Dec 21;141(12):946-56. Review.PMID: 15611492 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives.

    Dalpiaz A, Leo E, Vitali F, Pavan B, Scatturin A, Bortolotti F, Manfredini S, Durini E, Forni F, Brina B, Vandelli MA.

    Biomaterials. 2005 Apr;26(11):1299-306.PMID: 15475060 [PubMed - indexed for MEDLINE]Related articles

    29.

    Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules.

    Manfredini S, Vertuani S, Pavan B, Vitali F, Scaglianti M, Bortolotti F, Biondi C, Scatturin A, Prasad P, Dalpiaz A.

    Bioorg Med Chem. 2004 Oct 15;12(20):5453-63.PMID: 15388172 [PubMed - indexed for MEDLINE]Related articles

    30.

    Topical lidocaine patch therapy for myofascial pain.

    Dalpiaz AS, Lordon SP, Lipman AG.

    J Pain Palliat Care Pharmacother. 2004;18(3):15-34.PMID: 15364629 [PubMed - indexed for MEDLINE]Related articles

    31.

    Conformational aspects of human formyl-peptide receptor agonists.

    Dalpiaz A, Vertuani G, Scatturin A, Vitali F, Varani K, Spisani S.

    Arzneimittelforschung. 2003;53(11):793-8.PMID: 14677376 [PubMed - indexed for MEDLINE]Related articles

    32.

    Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity of ascorbyl nipecotic acid conjugate.

    Dalpiaz A, Pavan B, Scaglianti M, Vitali F, Bortolotti F, Biondi C, Scatturin A, Tanganelli S, Ferraro L, Prasad P, Manfredini S.

    J Pharm Sci. 2004 Jan;93(1):78-85.PMID: 14648638 [PubMed - indexed for MEDLINE]Related articles

    33.

    Myofascial pain response to topical lidocaine patch therapy: case report.

    Dalpiaz AS, Dodds TA.

    J Pain Palliat Care Pharmacother. 2002;16(1):99-104.PMID: 14650453 [PubMed - indexed for MEDLINE]Related articles

    34.

    Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy) in allergic rhinitis treatment.

    Fundueanu G, Constantin M, Dalpiaz A, Bortolotti F, Cortesi R, Ascenzi P, Menegatti E.

    Biomaterials. 2004 Jan;25(1):159-70.PMID: 14580919 [PubMed - indexed for MEDLINE]Related articles

    35.

    Peptide derivatives as agonists or antagonists of formylpeptide receptors: analysis of their effects on neutrophils.

    Dalpiaz A, Scatturin A.

    Mini Rev Med Chem. 2003 May;3(3):167-73. Review.PMID: 12570833 [PubMed - indexed for MEDLINE]Related articles

    36.

    Studies on human neutrophil biological functions by means of formyl-peptide receptor agonists and antagonists.

    Dalpiaz A, Spisani S, Biondi C, Fabbri E, Nalli M, Ferretti ME.

    Curr Drug Targets Immune Endocr Metabol Disord. 2003 Mar;3(1):33-42. Review.PMID: 12570724 [PubMed - indexed for MEDLINE]Related articles

    37.

    Adenosine A(1) receptor: analysis of the potential therapeutic effects obtained by its activation in the central nervous system.

    Dalpiaz A, Manfredini S.

    Curr Med Chem. 2002 Nov;9(21):1923-37. Review.PMID: 12369876 [PubMed - indexed for MEDLINE]Related articles

    38.

    Poly(lactic acid) microspheres for the sustained release of antiischemic agents.

    Dalpiaz A, Scatturin A, Pavan B, Biondi C, Vandelli MA, Forni F.

    Int J Pharm. 2002 Aug 21;242(1-2):115-20.PMID: 12176233 [PubMed - indexed for MEDLINE]Related articles

    39.

    Temperature dependence of the affinity enhancement of selective adenosine A1 receptor agonism: a thermodynamic analysis.

    Dalpiaz A, Pavan B, Ngos FN, Franchetti P, IJzerman AP.

    Eur J Pharmacol. 2002 Jul 19;448(2-3):123-31.PMID: 12144931 [PubMed - indexed for MEDLINE]Related articles

    40.

    C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor.

    Dalpiaz A, Ferretti ME, Vertuani G, Traniello S, Scatturin A, Spisani S.

    Eur J Pharmacol. 2002 Feb 2;436(3):187-96.PMID: 11858798 [PubMed - indexed for MEDLINE]Related articles

    41.

    Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity.

    Manfredini S, Pavan B, Vertuani S, Scaglianti M, Compagnone D, Biondi C, Scatturin A, Tanganelli S, Ferraro L, Prasad P, Dalpiaz A.

    J Med Chem. 2002 Jan 31;45(3):559-62.PMID: 11806707 [PubMed - indexed for MEDLINE]Related articles

    42.

    Poly(lactic acid) microspheres for the sustained release of a selective A1 receptor agonist.

    Dalpiaz A, Scatturin A, Pavan B, Biondi C, Vandelli MA, Forni F.

    J Control Release. 2001 Jun 15;73(2-3):303-13.PMID: 11516507 [PubMed - indexed for MEDLINE]Related articles

    43.

    Synthesis and study of 5'-ester prodrugs of N6-cyclopentyladenosine, a selective A1 receptor agonist.

    Dalpiaz A, Scatturin A, Menegatti E, Bortolotti F, Pavan B, Biondi C, Durini E, Manfredini S.

    Pharm Res. 2001 Apr;18(4):531-6.PMID: 11451042 [PubMed - indexed for MEDLINE]Related articles

    44.

    Determination of the adenosine A(1) agonist N(6)-cyclopentyladenosine in rat blood by solid-phase extraction and HPLC.

    Scalia S, Simeoni S, Dalpiaz A, Villani S.

    J Pharm Biomed Anal. 2001 Mar;24(5-6):1131-6.PMID: 11248509 [PubMed - indexed for MEDLINE]Related articles

    45.

    Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors.

    Dalpiaz A, Scatturin A, Vertuani G, Pecoraro R, Borea PA, Varani K, Traniello S, Spisani S.

    Eur J Pharmacol. 2001 Jan 12;411(3):327-33.PMID: 11164392 [PubMed - indexed for MEDLINE]Related articles

    46.

    Can thermodynamic measurements of receptor binding yield information on drug affinity and efficacy?

    Borea PA, Dalpiaz A, Varani K, Gilli P, Gilli G.

    Biochem Pharmacol. 2000 Dec 1;60(11):1549-56. Review.PMID: 11077036 [PubMed - indexed for MEDLINE]Related articles

    47.

    Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands.

    Dalpiaz A, Scatturin A, Varani K, Pecoraro R, Pavan B, Borea PA.

    Life Sci. 2000 Aug 11;67(12):1517-24.PMID: 10983847 [PubMed - indexed for MEDLINE]Related articles

    48.

    Conformational aspects of human formylpeptide receptor antagonists.

    Scatturin A, Vertuani G, Pecoraro R, Dalpiaz A, Boggian M, Ferretti ME, Spisani S.

    Arzneimittelforschung. 1999 Oct;49(10):873-7.PMID: 10554666 [PubMed - indexed for MEDLINE]Related articles

    49.

    Thermodynamic in vitro studies as a method to investigate the pharmacodynamic behavior of adenosine A1 receptor ligands.

    Dalpiaz A, Scatturin A, Pavan B, Varani K, IJzerman AP, Andrea Borea P.

    Pharm Res. 1999 Jul;16(7):1054-8.PMID: 10450930 [PubMed - indexed for MEDLINE]Related articles

    50.

    Formylpeptide receptor antagonists: structure and activity.

    Dalpiaz A, Pecoraro R, Vertuani G, Spisani S, Rizzuti O, Fabbri E, Scatturin A.

    Boll Chim Farm. 1999 Mar;138(3):44-8. No abstract available. PMID: 10394703 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...